Semaglutide, sold under the brand names Wegovy, Ozempic, and Rybelsus, is a medication prescribed for targeted weight loss in certain individuals.
It is also utilized to lower blood sugar levels and mitigate the likelihood of significant cardiovascular incidents like heart attacks or strokes in patients with type 2 diabetes. As a GLP-1 agonist, Semaglutide functions by enhancing insulin release, decreasing the secretion of glucagon, slowing down gastric emptying, and curbing appetite.